Related Experiment Video

Updated: Jun 28, 2026

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
07:18

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease

Malabendu Jana1, Carlos A Palencia, Kalipada Pahan

  • 1Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|November 5, 2008
PubMed

Insights

Toll-like receptor 2 (TLR2) mediates amyloid-beta (Abeta) peptide-induced microglial activation in Alzheimer's disease (AD). This pathway is crucial for the inflammatory response in AD brains, highlighting TLR2 as a potential therapeutic target.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Microglial activation is a key pathological feature in Alzheimer's disease (AD).
  • Fibrillar amyloid-beta (Abeta) peptides are implicated in microglial activation in AD.
  • The precise mechanisms of Abeta-induced microglial activation remain unclear.

Purpose of the Study:

  • To investigate the role of Toll-like receptor 2 (TLR2) in mediating Abeta peptide-induced microglial activation.
  • To elucidate the signaling pathways involved in Abeta-driven neuroinflammation.

Main Methods:

  • Utilized primary mouse microglia and BV-2 microglial cell lines.
  • Employed antisense knockdown and functional blocking antibodies against TLR2.
  • Examined Abeta1-42-induced expression of inflammatory mediators and microglial markers.
  • Investigated microglial responses in TLR2 knockout (TLR2-/-) mice and MyD88 knockdown models.

Main Results:

  • Fibrillar Abeta1-42 induced pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6) and microglial markers (CD11b, CD11c, CD68).
  • TLR2 knockdown or blockade significantly suppressed Abeta1-42-induced inflammatory responses.
  • Microglia from TLR2-/- mice showed no response to Abeta1-42 peptides.
  • In vivo studies in TLR2-/- mice confirmed the essential role of TLR2 in Abeta-induced microglial activation.
  • TLR2 ligation alone activated microglia, and MyD88 knockdown inhibited Abeta1-42-induced inflammation.

Conclusions:

  • TLR2 signaling is critical for mediating fibrillar Abeta peptide-induced microglial activation.
  • The TLR2 pathway plays a significant role in the neuroinflammatory processes of Alzheimer's disease.
  • Targeting the TLR2 pathway may offer a novel therapeutic strategy for AD.

More Related Videos

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease09:33

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

Rapid Generation of Amyloid from Native Proteins In vitro05:48

Rapid Generation of Amyloid from Native Proteins In vitro

Published on: December 5, 2013

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...